BACKGROUND. Body dysmorphic disorder (BDD) is a syndrome characterized by distress secondary to imagined or minor defects in one's appearance. Although it is a psychiatric disorder, most affected patients present to the dermatologist or plastic surgeon to improve their perceived defect. OBJECTIVE. The objective was to review the literature on BDD, examining the epidemiology, etiology, clinical features, diagnostic criteria, and treatment of the disorder. METHODS. Three representative cases of BDD are presented; in addition, a search of MEDLINE was completed and a review of all published data on BDD was performed.
A 24-year-old female esthetician presented to our office for evaluation of her "severe, cystic acne." She reported that she suffered from extensive breakouts, which were so severe that she was unable to go anywhere except to work. She admitted to manipulating her lesions. On examination, she had fewer than 10 small 1 to 2 mm excoriated papules on her forehead and nose. She was given benzoyl peroxide and tretinoin 0.025% cream. Over a period of 3 weeks, she contacted the office multiple times, stating that her symptoms had not improved. She demanded to speak to the physician during the physician's clinic time. On returning a message, the physician was told not to call the patient at work because she was with clients. On follow-up visits, the patient continued to complain that her skin was "ugly" and "imperfect." She reported difficulty in performing her job duties owing to her perceived ugliness. On examination, there was no active acne or excoriation. She persists in calling the office frequently, requiring reassurance.
Case 2
A 19-year-old female student presented to our office for a "dark spot" on the left cheek, which she stated had been present for 2 to 3 years. On examination, there was no appreciable area of darkened skin; however, there were less than five comedones on her face. She was treated with azelaic acid for 4 months. She returned with no comedones but continued to complain of a dark area on the left cheek. She was given tretinoin in increasing strengths over the next year but found no improvement in the noted "dark spot." She was then given tazarotene cream. When she returned to the office, she was very unhappy with the lack of improvement in the spot. Extensive discussion as to what lighting and mirror magnification were used when she sees the spot revealed that she is able to see the spot in all mirrors under dim light. Dermatoscopic examination of "involved" and uninvolved skin was explored, with no evidence of increased pigment in the affected area. A handheld light was placed at varying angles, which revealed a slight difference in texture in the affected area, creating a slightly different shadow across the patient's pores. After this explanation, the patient changed the focus of her com-plaint to the coarse texture of the skin in that area. She began to request dermabrasion or chemical peel treatment. The treating physician advised against these treatments for such a minor defect because the potential for side effects from the procedure was greater than the chance of improvement. The physician has continued to deny any surgical requests. She continues to be unhappy with her condition and has suggested that she will find a physician who will perform surgical treatment.
Case 3
A 43-year-old white female presented to our clinic for treatment of facial darkening after she was placed on hormone replacement therapy. She reported that her discoloration "affects [her] self-esteem and quality of life." She had not used any over-the-counter treatments. On examination, there were lightly hyperpigmented brown macules over the forehead, bilateral cheeks, and chin. The patient was given azelaic acid cream for use over the entire face at night and hydroquinone 4% cream with sunscreen in the morning.
The patient began calling to complain on an almost weekly basis that the medication was not helping her condition. After 3 months, the patient was changed to Tri-Luma (Galderma, Fort Worth, TX, USA) cream. One week later, she called our office complaining that she had increased hair growth in the areas on which she had been applying the medication. She reported that she was not able to eat or sleep because of her damaged appearance. On presentation to the clinic later that day, there was no evidence of terminal facial or neck hair; only normal vellus hairs were present. The light brown macules on the patient's face were improved over her baseline. The patient continued to insist that her face was deformed because of the new medication despite our attempts to demonstrate that there was no increase in her facial hair (ie, photographs, consultation with another dermatologist).
The patient left our office after a suggestion was made that she suffered from BDD and that she should see one of our psychiatrists. Later, our office was contacted by Tri-Luma's manufacturer, expressing concern because the patient had repeatedly called and written the company about her "reaction." After numerous telephone calls to the patient, including telephone calls to our hospital's esthetician, the patient agreed to seek psychiatric help. She is now undergoing psychiatric counseling and is on a serotonin reuptake inhibitor but continues to focus on her appearance.
These three cases illustrate the frustrations encountered by physicians treating patients afflicted with BDD. All three patients have extremely minimal defects for which they felt medical treatment was ineffective. It is easy for a treating physician to pursue increasingly involved treat-ments to treat patients with this disorder. However, the likelihood that the patient would be satisfied even after extensive procedures is very minimal. As the last case illustrates, treatment may result in heightened complaints.
Epidemiology
Studies suggest that 1 to 2% of the general population are affected by BDD, with equal distribution between the sexes. 3 There is some evidence that BDD is inherited. BDD is four times more prevalent in first-degree relatives of patients with BDD. 4 Studies performed in the general populations of both the United States and Italy confirm a 1year prevalence of 0.7%. 5, 6 College students demonstrate an increased rate of BDD (4-13%). [7] [8] [9] Interestingly, several studies noted that Americans tend to be more concerned with their physical appearance than other nationalities. 10, 11 This correlates with the higher rates of BDD found in American students (13%) compared with German students (5.3%) and argues for societal factors in the development of BDD.
Increased prevalence of BDD is found in specific medical populations. A recent screening of dermatology patients revealed a prevalence of BDD of 11.9%. 12 In the cosmetic surgery population, rates of BDD range from 2 to 7%. [13] [14] [15] [16] In a Japanese survey of 415 consecutive patients seeking cosmetic surgery, 65% of male subjects and 40% of female subjects were classified as having any mental disorder, with 20% of male subjects and 3% of female subjects meeting the criteria for BDD. 16 Rates of BDD are also increased among patients with other psychiatric diseases. Phillips and colleagues reported a 13.8% lifetime history of BDD among patients with depression. 17 Likewise, BDD is found in 6.7% of patients with anxiety disorder. 18 Among anxiety subjects, patients with social phobias are most likely to suffer from BDD. 19 Patients with obsessive-compulsive disorder (OCD) are also at increased risk of BDD. 20 Additionally, patients with BDD and depression are likely to have one of the following personality disorders: histrionic, avoidant, or dependent. 21 Importantly, patients who suffer from depression and BDD demonstrate worse psychosocial functioning than their depressed counterparts without BDD. Patients with BDD tend to have earlier onset of their depression (during midadolescence) and a more chronic course of depression. 17, 21 Psychiatrists worry that patients with BDD with depression have an increased likelihood of suicide attempt in contrast to patients with depression only. Phillips and colleagues evaluated a group of 130 patients with BDD, finding that 29% of these patients had attempted suicide 22 ; of these patients, the greatest risk of suicide was found in women with perceived facial defects. 12 Indeed, suicide secondary to BDD has been reported in the dermatologic literature. 23, 24 
Etiology
Although some psychiatrists classify BDD as a subtype of OCD, there are subtle distinctions. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) states that OCD is marked by the presence of a recurrent, intrusive obsession, which produces a behavioral response, a compulsion. 1 Patients with BDD often perform compulsive "checks" of their perceived defects, 25 which is similar to the behavior of patients with OCD. However, patients with OCD maintain insight into their disease, realizing that it affects their ability to function. 1 In contrast, patients with BDD lack insight into their disease. Although they are obsessed with a perceived or possibly minor imperfection, they do not necessarily generate a compulsion. Rarely do affected patients realize the impact that the disease has on their ability to function.
Other authors link BDD with anxiety disorders. Japanese psychiatrists traditionally label BDD as a subtype of anthrophobia or social phobia. 16 Anxiety disorders can become generalized, in which the patient does not want to leave the house. Likewise, BDD may become so severe that the perceived defect prevents the patient from entering public areas. Both sets of patients avoid situations in which they may be scrutinized. Patients with both social phobia and BDD demonstrate distraction by emotional cues and words related to their concerns. 26 Both sets of patients have been shown to interpret ambiguous information as threatening. 27 Nevertheless, the DSM-IV categorizes BDD as a somatoform disorder. Somatoform disorders are a group of psychological disorders in which the patient reports physical symptoms despite the absence of a medical condition. 28 Often patients with a somatoform disorder pursue extensive treatments, yielding long medical and surgical histories.
One hypothesis for the origin of BDD comes from an understanding of the psychological body image. The psychological body image is represented by the internal model a person maintains of self, which functions for recognition of posture, movement, and localization of sensation. 29 Koblenzer stated that this image is formed from sensory input that bombards the infant during early life. Because memory requires emotional input, any perceptual body image information that is stored is associated with the emotional milieu from which it took place. Thus, when the emotional climate is disturbed, body image may become distorted. 30 In addition to emotional input, some authors suggest that selective attention plays a part in the development of BDD. 31 Patients with BDD may selectively attend to their perceived defect, which results in reinforcement of the disorder. Certainly, patients with BDD check the defect; a recent survey revealed that 80% of patients with BDD may be classified as "checkers." 25, 32 It is known that patients with social phobia are at risk of developing excessive selffocused attention. 33 Veale and colleagues postulated that in patients with BDD who become increasingly selfisolated, various thinking errors begin to occur. Patients with BDD may have errors of "emotional reasoning": because they feel inadequate, they believe that they are, indeed, inadequate. They may also have the error of "mind reading," assuming that others see the defect and feel the same way. 32 Another hypothesis to explain the phenomenon of BDD was proposed by a plastic surgeon. He explained that there are degrees of "aestheticality"-a variation in esthetic proportions. 34 Harris explained that patients with BDD, owing to their sensitive esthetic nature, are similar to "real" patients who seek treatment, although their disfigurement is perhaps minimal in the eye of the evaluator. This hypothesis suggests that persons with BDD are more likely to pursue other interests that lie along esthetic lines.
Indeed, there is an association between BDD and an interest in esthetics. Recently, 100 patients with BDD were compared with 300 patients with other psychiatric disorders. Twenty percent of the patients with BDD had an occupation or education in art and design compared with 4% of depressed patients, 3% of anxious patients, and 0% of patients with posttraumatic stress disorder. 35 Another study revealed that the proportion of 146 subjects with BDD who were employed as artists was twice that in the general population but did not examine the educational background of the subjects. 36 Because BDD is typically acquired in adolescence, this raises the question of whether the tendency toward BDD causes the patient to develop an interest in the arts or esthetics or whether the predisposition toward esthetics may increase the likelihood of BDD. Veale noted that patients with BDD have idealized values about the importance of appearance and esthetics, which may become overidentified with "self." 37 Another possible association with BDD may be medical illness. Of late, there have been two published cases of medical illness followed by social isolation and resultant BDD. The first patient developed Bell's palsy at age 15 years; despite eventual resolution of his palsy, he continued to complain of facial deformity and avoid social contact. Likewise, another patient, age 22 years, developed ulcerative colitis followed by a belief that his skin was deformed and dry. 38 The authors suggested that inflammatory mediators or cytokines alter the neurochemical milieu of the brain. Indeed, there are reports suggesting that certain cytokines function to suppress serotonin synthesis. 39 Another hypothesis for the etiology of BDD is found in a case report of a patient who, following encephalitis, developed BDD. Brain imaging revealed atrophy of the frontotemporal lobe. 40 However, there have been no case-controlled brain imaging studies of patients with BDD to confirm or refute this finding.
Clinical Features of BDD
Onset of BDD is usually during adolescence. Patients seek medical and cosmetic treatment of their perceived defect. Phillips and colleagues examined which physicians and treatments are most sought after by patients with BDD. Importantly, dermatologic treatment was most commonly sought, by 45.2% of patients. Antibiotics for perceived acne were the most common treatment; however, patients with BDD also received minoxidil and isotretinoin. Plastic and reconstructive surgery was pursued by 23.2% of patients, with rhinoplasty being the most common procedure. There was no association between the number of treatments sought and the severity of the BDD. 41 The most common complaints involve perceived facial defects, 42 such as skin blemishes (> 60%), 43 hair (> 50%), 43, 44 and nasal shape (> 40%). 43 Less commonly, patients may be concerned with the size of their genitalia, muscularity, breast size or shape, and buttock shape. 13 Many patients with BDD have poor insight into their disease. Complaints may become firm, fixed, false beliefs or delusions. 45 Delusional patients have significantly more impairment in school or work functioning and are more likely to become reclusive than patients who are not delusional. 46 Owing to the near-delusional or delusional nature of the complaint, patients with BDD often have unreasonable expectations of their provider.
BDD may result in extreme forms of behavior. Patients often engage in repeated checking; this may be checking of their perceived defect or their defect's "camouflage." In a survey of 50 patients with BDD, it was found that at least 80% performed some form of "defect check" on at least half of the days during the previous month. 25 Checking may evolve into repeated attempts to "correct" the perceived defect. In extreme cases, patients' attempts to correct their perceived faults may become life threatening. O'Sullivan and colleagues reported a patient who attempted to remove skin irregularities, eventually becoming preoccupied with a skin imperfection on her neck. The patient used tweezers to create a defect through her dermis, subcuticular tissue, and neck musculature, exposing the carotid artery. 47 Patients repeatedly ask their physician for reassurance and treatments for their perceived defects. 48 These patients are consistently referred to as "the most difficult dermatology patients to treat," demanding laser abrasions, dermabrasions, and isotretinoin treatments that are not medically or cosmetically necessary. 49 Such patients may "doctor shop" in an attempt to find a physician willing to perform a desired procedure. Other patients may make litigious threats or even threats directed at the well-being of the treating dermatologist. 49 In fact, there are reports suggesting that male patients suffering from BDD pose a particular risk of violent behavior. 50 Perugi and colleagues posed the following question:
"Are you ever so enraged and in despair that you lose control and become insulting, aggressive or violent towards your relatives and friends?" They discovered positive responses in 29% of males and 46% of females surveyed. 44 Another study revealed that 38% of 33 adolescent patients reported a history of violence secondary to BDD. 51 Additional reports demonstrated that male patients tend not to complain directly about their perceived defect; they will tend to apply any anxiety to physical outlets, such as violence or aggression. 52 Indeed, Cotterill mentioned the murders of two plastic surgeons and one dermatologist, each physician the victim of an unsatisfied patient with BDD. 49 
Diagnosis
Key aspects of the patient's history may facilitate the diagnosis of BDD. Inquiry about the following topics 13, 53 will help confirm suspicions of BDD:
What area in particular concerns you and why?
Has this defect caused you great emotional distress?
Does this defect impair your ability to perform at work or school?
Has the defect impacted your social life? Do you take time to check the defect?
How much time do you spend correcting or concealing the defect?
Does this defect affect you sexually?
What treatments have you sought to treat this condition?
What treatment outcome do you expect?
Indeed, screening questionnaires have been developed for use by dermatologists 53 and, if used with office intake questionnaires, may highlight a patient with BDD.
Owing to the risk of suicide in patients in BDD, the most important aspect of assessing the patient is screening for suicidal ideation. Questions to ask a patient to screen for suicidal ideation include the following:
Have you ever thought of hurting yourself?
If you were to hurt yourself, what would you do?
Do you have any intention of carrying out this plan?
Have you taken any steps to carry out this plan?
Likewise, persons who may seem delusional in regard to their defect should be assessed for other delusions to rule out schizophrenia. Organic disease may be excluded by testing orientation, memory, and the ability to concentrate. 13 If a patient has a clinical history suspicious for BDD, careful physical examination must be performed to assess the presence or degree of the severity of the clinical complaint. Patients with BDD will have either a normal appearance or a minimal defect. However, their demeanor may be anxious or depressed.
Treatment
Cosmetic and dermatologic treatment is not generally effective in cases of BDD because the patient's defect is often exceedingly minimal or imagined. Unfortunately, patients with BDD who sought treatment reported that 61.4% of treatments resulted in no change in their initial complaint; some patients found that treatment caused worsening of the initial complaint. 41 There is also a legal risk in treating a patient with BDD. In New York, a patient with a psychiatric history who had undergone multiple cosmetic procedures was considered by the judicial majority to have decreased capacity for informed consent. Thus, the surgeon had a responsibility to discuss any unreasonable expectations and risks and possibly to refuse the case. 54 Indeed, it is well documented in the plastic surgery literature that if a patient is believed to be incapable of coping with an imperfect result, the treating surgeon should refuse the case. 15, 49, 55 Treatment for BDD includes both psychiatric medicinal therapies and psychotherapeutic options. Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), has been demonstrated in several case series 22, 45, 56 and open-label trials 57, 58 to be an effective medication for BDD. A placebo-controlled study demonstrated a 53% response rate to the SSRI fluoxetine, in addition to a good safety profile. Effective doses of fluoxetine ranged from 20 to 80 mg/d. 59 Interestingly, patients with a delusional component to their BDD also responded well to SSRIs. 59, 60 This is in contrast to case reports of antipsychotic failures in delusional patients with BDD. 22, 45 Other treatment options include cognitive-behavioral therapy. 32 Cognitive therapy is aimed at changing the faulty thinking or belief systems of the patient. Behavioral therapy is based on learning theories; it may include aversion therapy, implosive therapy, operant conditioning, or systematic desensitization. Veale and colleagues performed a 12-week randomized controlled study of cognitive therapy techniques in patients with BDD. Methods included encouraging use of a continuum to rate the patient's "defectiveness" so that the patient realizes that he or she is in the middle of the continuum, reversed role play, and collecting positive or neutral information about the patient's assumptions. Using depression or anxiety and BDD questionnaires, they demonstrated a 50% reduction in the quantifiable symptoms of BDD. 32 Further complicating treatment of BDD is the fact that patients may demonstrate varying degrees of the disorder. For example, some patients may be concerned with a real defect in appearance in contrast to an imagined defect. Sar-wer and colleagues mentioned seven patients who sought scar revision treatments for significant scars. However, each of these patients reported preoccupations with the scars, which led to impaired functioning. These authors broadened the scope of BDD to include these patients. 14, 15 In circumstances in which a significant, real defect exists, Sarwer and colleagues suggested that a careful combination of surgical and psychiatric therapies may be considered. 15 Unfortunately, most clinicians discover that patients with BDD are unwilling to seek psychiatric help. I prefer to begin therapy with a SSRI while providing information on BDD. Often, if a nonjudgmental, accepting attitude is conveyed to patients, they may consider psychiatric referral in the future.
